Treatment of catatonia with olanzapine and amantadine

Psychosomatics

Volumn 48, Issue 6, 2007, Pages 534-536

  Babington, Parker W ^a   Spiegel, David R ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ATYPICAL ANTIPSYCHOTIC AGENT; LORAZEPAM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; OLANZAPINE;

ADULT; ARTICLE; CASE REPORT; CATATONIA; CLINICAL EXAMINATION; DISEASE COURSE; DRUG EFFICACY; DRUG MECHANISM; DRUG WITHDRAWAL; FEMALE; HUMAN; SEDATION; SIDE EFFECT;

EID: 35948951182     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.48.6.534     Document Type: Letter

References (14)

1. Taylor MA, Fink M: Catatonia in psychiatric classification: a home of its own. Am J Psychiatry 2003; 160:1233-1241
2. Fink M, Taylor MA: Catatonia: A Clinician's Guide to Diagnosis and Treatment. Cambridge, UK, Cambridge University Press, 2003
3. Rosebush PI, Mazurek MF: A consideration of the mechanisms by which lorazepam might treat catatonia. J Clin Psychiatry 1991; 52:187-188
4. Salam SA, Pillai AK, Beresford TP: Lorazepam for psychogenic catatonia. Am J Psychiatry 1987; 144:1082-1083
5. Cook EH, Olson K, Pliskin N: Response of organic catatonia to risperidone. Arch Gen Psychiatry 1996; 53:82-83
6. Van Den Eede F, Van Hecke J, Van Dalfsen A, et al: The use of atypical antipsychotics in the treatment of catatonia. Eur Psychiatry 2005; 20:422-429
7. Northoff G, Lins H, Boker H, et al: Therapeutic efficacy of N-methyl D-aspartate antagonist amantadine in febrile catatonia. J Clin Psychopharmacol 1999; 19:484-486
8. Carroll BT, Thomas C, Kameshwari J, et al: Treating persistent catatonia when benzodiazepines fail. Curr Psychiatry Online 2005; vol. 4, no. 3
9. Muir KW, Grosset DG, Lees KR: Clinical pharmacology of CNS 1102 in volunteers. Ann N Y Acad Sci 1995; 765:279-289
10. McDaniel WW, Spiegel DR, Sahota AK: Topiramate effect in catatonia: a case series. J Neuropsychiatry Clin Neurosci 2006; 18:234-238
11. Northoff Georg: Neuroimaging and neurophysiology, in Catatonia: From Psychopathology to Neurobiology. Edited by Caroff SN, Mann SC, Francis A, et al. Washington, DC, American Psychiatric Publishing, 2004, pp 77-91
12. Northoff G, Eckert J, Fritze J: Glutamatergic dysfunction in catatonia? successful treatment of three acute akinetic catatonic patients with the NMDA antagonist amantadine. J Neurol Neurosurg Psychiatry 1997; 62:404-406
13. Huang TL: Lorazepam and diazepam rapidly relieve catatonic signs in patients with schizophrenia. Psychiatry Clin Neurosci 2005; 59:52-55
14. Wermeling DP, Miller JL, Archer SM, et al: Bioavailability and pharmacokinetics of lorazepam after intranasal, intravenous, and intramuscular administration. J Clin Pharmacol 2001; 41:1225-1231